Lilly Presents New Findings on Stigma Faced by People with Migraine Based on Interim Results from the OVERCOME Observational Study

INDIANAPOLIS, July 13, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the presentation of data about personal attitudes toward migraine among people without the disease.1 These data are from the OVERCOME (Observational Survey of the Epidemiology, Treatment and Care ...

from PR Newswire: https://ift.tt/2XJFaXG